Utilisation de la kétamine en psychiatrie : mise à jour [Use of ketamine in psychiatry: an update]

Details

Serval ID
serval:BIB_2CC5D1F0A51F
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Utilisation de la kétamine en psychiatrie : mise à jour [Use of ketamine in psychiatry: an update]
Journal
Revue medicale suisse
Author(s)
Clerc M.T., Rosenhagen-Lapoirie M., Von Gunten A.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
31/08/2022
Peer-reviewed
Oui
Volume
18
Number
793
Pages
1626-1629
Language
french
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
Ketamine has demonstrated at a lower dose a robust and rapid antidepressant effect due to a mechanism of action different from conventional treatments. It is now included in several international recommendations on treatment-resistant depression. Ketamine may be used in both out- or in-patient settings, generally by way of intravenous or intranasal formulations provided the fulfillment of safety requirements. There is a growing interest in the use of ketamine for other resistant psychiatric disorders such as anxiety and substance use disorders. Ketamine proves an innovating and promising treatment that extends the range of therapeutic possibilities in psychiatry. We propose here to review its current clinical use.
Keywords
Administration, Intravenous, Antidepressive Agents/therapeutic use, Depressive Disorder, Treatment-Resistant/drug therapy, Humans, Ketamine/therapeutic use, Psychiatry
Pubmed
Create date
20/09/2022 14:16
Last modification date
23/09/2022 5:38
Usage data